Different Roles of Mast Cells in Obesity and Diabetes: Lessons from Experimental Animals and Humans

DSpace/Manakin Repository

Different Roles of Mast Cells in Obesity and Diabetes: Lessons from Experimental Animals and Humans

Citable link to this page

 

 
Title: Different Roles of Mast Cells in Obesity and Diabetes: Lessons from Experimental Animals and Humans
Author: Shi, Michael A.; Shi, Guo-Ping

Note: Order does not necessarily reflect citation order of authors.

Citation: Shi, Michael A., and Guo-Ping Shi. 2012. Different roles of mast cells in obesity and diabetes: Lessons from experimental animals and humans. Frontiers in Immunology 3:7.
Full Text & Related Files:
Abstract: Mast cells (MCs) play an important role in allergic hyperresponsiveness and in defending microorganism infections. Recent studies of experimental animals and humans have suggested that MCs participate in obesity and diabetes. MC distribution and activities in adipose tissues may vary, depending on the locations of different adipose tissues. In addition to releasing inflammatory mediators to affect adipose tissue extracellular matrix remodeling and to promote inflammatory cell recruitment and proliferation, MCs directly and indirectly interact and activate adipose tissue cells, including adipocytes and recruited inflammatory cells. Plasma MC protease levels are significantly higher in obese patients than in lean subjects. Experimental obese animals lose body weight after MC inactivation. MC functions in diabetes are even more complicated, and depend on the type of diabetes and on different diabetic complications. Both plasma MC proteases and MC activation essential immunoglobulin E levels are significant risk factors for human pre-diabetes and diabetes mellitus. MC stabilization prevents diet-induced diabetes and improves pre-established diabetes in experimental animals. MC depletion or inactivation can improve diet-induced type 2 diabetes and some forms of type 1 diabetes, but also can worsen other forms of type 1 diabetes, at least in experimental animals. Observations from animal and human studies have suggested beneficial effects of treating diabetic patients with MC stabilizers. Some diabetic patients may benefit from enhancing MC survival and proliferation – hypotheses that merit detailed basic researches and clinical studies.
Published Version: doi:10.3389/fimmu.2012.00007
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341969/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10364594
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters